Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's Disease

American Journal of Speech-Language Pathology

Volumn 16, Issue 2, 2007, Pages 96-107

  Spielman, Jennifer ^a   Ramig, Lorraine O ^b   Mahler, Leslie ^b,d   Halpern, Angela ^a   Gavin, William J ^c  

^a University of Arizona   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Clinical research; Dysarthria; Parkinson's disease; Voice treatment

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; DYSARTHRIA; FEMALE; FOLLOW UP; HUMAN; LARYNX DISORDER; LEARNING; MALE; METHODOLOGY; MIDDLE AGED; PARKINSON DISEASE; SELF CARE; SOUND DETECTION; SPEECH; SPEECH ANALYSIS; SPEECH REHABILITATION; SPEECH THERAPY; TREATMENT OUTCOME; VOICE;

AGED; AGED, 80 AND OVER; DYSARTHRIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PRACTICE (PSYCHOLOGY); SELF CARE; SOUND SPECTROGRAPHY; SPEECH ACOUSTICS; SPEECH PRODUCTION MEASUREMENT; SPEECH THERAPY; VOICE DISORDERS; VOICE QUALITY; VOICE TRAINING;

EID: 34249663245     PISSN: 10580360     EISSN: 15589110     Source Type: Journal    
DOI: 10.1044/1058-0360(2007/014)     Document Type: Article

References (63)

1. Allan, C. M. (1970). Treatment of nonfluent speech resulting from neurological disease - treatment of dysarthria. British Journal of Disorders of Communication, 5, 3-5.
2. Baker, K., Ramig, L., Luschei, E., & Smith, M. (1998). Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology, 51, 1592-1598.
3. Baumgartner, C., Sapir, S., & Ramig, L. (2001). Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson's disease. Journal of Voice, 15(1), 105-114.
4. Berardelli, A., Rothwell, J. C., Thompson, P. D., & Hallett, M. (2001). Pathophysiology of bradykinesia in Parkinson's disease. Brain, 124, 2131-2146.
5. Brown, R. G., & Marsden, C. D. (1991). Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain, 114, 215-231.
6. Cole, R., Ramig, L., Yan, J., Halpern, A., & Van Vuuren, S. (2004, October). Animated agent enhanced LSVT virtual therapy system. Poster presented at the "Enhancing the Quality of Life for People with Cognitive Disabilities through Technology" conference at the Coleman Institute for Cognitive Disabilities, Denver, CO.
7. Cotman, C. W., & Berchtold, N. C. (2002). Exercise: A behavioral intervention to enhance brain health and plasticity. Trends in Neurosciences, 25(6), 295-301.
8. Coull, J., Tremblay, L., & Elliot, D. (2001). Examining the specificity of practice hypothesis: Is learning modality specific? Research Quarterly for Exercise and Sport, 72, 345-354.
9. Damiano, A. (1996). The Sickness Impact Profile user's manual and interpretation guide. Baltimore: The Johns Hopkins University.
10. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969a). Clusters of deviant speech dimensions in the dysarthias. Journal of Speech and Hearing Research, 12, 462-496.
11. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969b). Differential diagnosis patterns of dysarthria. Journal of Speech and Hearing Research, 12, 246-249.
12. Darley, F. L., Aronson, A. E., & Brown, J. R. (1975). Motor speech disorders. Philadelphia: W. B. Saunders.
13. Desmurget, M., Grafton, S. T., Vindras, P., Grea, H., & Turner, R. S. (2004). The basal ganglia network mediates the planning of movement amplitude. The European Journal of Neuroscience, 19, 2871-2880.
14. Dromey, C., Ramig, L. O., & Johnson, A. B. (1995). Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: A case study. Journal of Speech and Hearing Research, 38, 751-764.
15. El-Sharkawi, A., Ramig, L., Logemann, J. A., Paulosky, B. R., Rademaker, A. W., Smith, C. H., et al. (2002). Swallowing and voice effects of Lee Silverman Voice Treatment: A pilot study. Journal of Neurology, Neurosurgery, and Psychiatry, 72(1), 31-36.
16. Fairbanks, G. (1960). Voice and articulation drill book. New York: Harper.
17. Farley, B. G., Sherman, S., & Koshland, G. F. (2004). Shoulder muscle activity in Parkinson's disease during multijoint arm movements across a range of speeds. Experimental Brain Research, 154, 160-175.
18. Fisher, B. E., & Sullivan, K. J. (2001). Activity-dependent factors affecting poststroke functional outcomes. Topics in Stroke Rehabilitation, 8(3), 31-44.
19. Fox, C., Boliek, C., & Ramig, L. (2005). The impact of intensive voice treatment (LSVT) on speech intelligibility in children with spastic cerebral palsy [Abstract]. Movement Disorders, 20(10), 149.
20. Fox, C., Morrison, C., Ramig, L., & Sapir, S. (2002). Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease. American Journal of Speech-Language Pathology, 11, 111-123.
21. Fox, C., & Ramig, L. (1997). Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. American Journal of SpeechLanguage Pathology, 6(2), 85-94.
22. Hallett, M., & Khoshbin, S. (1980). A physiological mechanism' of bradykinesia. Brain, 103, 301-314.
23. Halpern, A., Matos, C., Ramig, L., Petska, J., Spielman, J., & Will, L. (2004, November). LSVTC: A PDA-supported speech treatment for Parkinson's disease. Poster presented at the Annual Convention of the American Speech-Language Hearing Association, Philadelphia.
24. Hill, A., & Theodores, D. G. (2002). Research into telehealth applications in speech-language pathology. Journal of Telemedicine and Telecare, 8, 187-196.
25. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427-433.
26. Jacobson, B., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M., & Newman, C. (1997). The Voice Handicap Index (VHI): Development and validation. American Journal of Speech-Language Pathology, 6(3), 66-70.
27. Johnson, J. A., & Pring, T. R. (1990). Speech therapy and Parkinson's disease: A review and further data. British Journal of Disorders of Communication, 25, 183-194.
28. King, J., Ramig, L., Lemke, J. H., & Horii, Y. (1994). Parkinson's disease: Longitudinal changes in acoustic parameters of phonation. Journal of Medical Speech-Language Pathology, 2, 29-42.
29. Kirk, R. E. (1995). Experimental design: Procedures for the behavioral sciences (3rd ed.). Pacific Grove, CA: Brooks/Cole.
30. Kleim, J., Jones, T., & Schallert, T. (2003). Motor enrichment and the induction of plasticity before or after brain injury. Neurochemical Research, 11, 1757-1769.
31. Liotti, M., Ramig, L. O., Vogel, D., New, P., Cook, C. I., Ingham, R. J., et al. (2003). Hypophonia in Parkinson's disease: Neural correlates of voice treatment revealed by PET. Neurology, 60, 432-440.
32. Luschei, E., Ramig, L., Baker, K., & Smith, M. (1999). Discharge characteristics of laryngeal single motor units during phonation in young and older adults and individuals with Parkinson disease. Journal of Neurophysiology, 81, 2131-2139.
33. Mashima, P. A., Birkmire Peters, D. P., Syms, M. J., Holtel, M. R., Brugess, L. P., & Peters, L. J. (2003). Telehealth: Voice therapy using telecommunications technology. American Journal of Speech-Language Pathology, 12, 432-439.
34. Mathworks. (1999). MATLAB (Version 5.3) [Computer software]. Natick, MA: Author.
35. McClean, M. D., & Tasko, S. M. (2002). Association of orofacial with laryngeal and respiratory motor output during speech. Experimental Brain Research, 146, 481-489.
36. Morris, M. E., & Iansek, R. (1996). Characteristics of motor disturbance in Parkinson's disease and strategies for movement rehabilitation. Human Movement Science, 15, 649-669.
37. Morris, M. E., Iansek, R., McGinley, J., Matyas, T., & Huxham, F. (2005). Three-dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder. Movement Disorders, 20(1), 40-50.
38. Narayana, S., Vogel, D., Brown, S., Franklin, C., Zhang, W., Lancaster, J., & Fox, P. (2005). Mechanisms of action of voice therapy in Parkinson's hypophonia: A PET study. Poster presented at the llth Annual Meeting of the Organization for Human Brain Mapping, Toronto, Ontario, Canada.
39. Pfann, K. D., Buchman, A. S., Comella, C. L., & Corcos, D. M. (2001). Control of movement distance in Parkinson's disease. Movement Disorders, 16, 1048-1065.
40. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., LimousinDowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinson's disease. The Lancet, 3, 547-556.
41. Ramig, L., Countryman, S., O'Brien, C., Hoehn, M., & Thompson, L. (1996). Intensive speech treatment fcr patients with Parkinson's disease: Short and long-term comparison of two techniques. Neurology, 47, 1496-1504.
42. Ramig, L., Countryman, S., Thompson, L., & Horii, Y. (1995). A comparison of two forms of intensive speech treatment for Parkinson's disease. Journal of Speech and Hearing Research, 38, 1232-1251.
43. Ramig, L., & Fox, C. (2006). LSVT® training and certification workshop binder. Tucson, AZ: LSVT Foundation.
44. Ramig, L., Sapir, S., Countryman, S., Pawlas, A., O'Brien, C., Hoehn, M., & Thompson, L. (2001). Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry, 71, 493-498.
45. Ramig, L., Sapir, S., Fox, C., & Countryman, S. (2001). Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal aged-matched controls. Movement Disorders, 16, 79-83.
46. Robertson, S. J., & Thomson, F. (1984). Speech therapy in Parkinson's disease: A study of the efficacy and long term effects of intensive treatment. British Journal of Disorders of Communication, 19, 213-224.
47. Robinson, T., Petska, J., Halpern, A., Ramig, L., & Fox, C. (2004, November). LSVT® and children with Down syndrome: Preliminary findings. Poster presented at the Annual Convention of the American Speech-Language-Hearing Association, Philadelphia.
48. Sapir, S., Pawlas, A., Ramig, L., Seeley, E., Fox, C., & Corboy, J. (2001). Effects of intensive phonatory-respiratory treatment (LSVT) on voice in two individuals with multiple sclerosis. Journal of Medical Speech-Language Pathology, 9(2), 141-151.
49. Sapir, S., Spielman, J., Countryman, S., Ramig, L., Hinds, S., Fox, C., & Story, B. (2003). Phonatory and articulatory changes in ataxic dysarthria following intensive voice therapy with the LSVT: A single subject study. American Journal of Speech-Language Pathology, 12, 387-399.
50. Sarno, M. T. (1968). Speech impairment in Parkinson's disease. Journal of Speech and Hearing Disorders, 49, 269-275.
51. Schmidt, R. A., & Lee, T. D. (1999). Motor control and learning: A behavioral emphasis (3rd ed.). Champaign, IL: Human Kinetics.
52. Schulz, G. M. (2002). The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson's disease: A review. Current Medicinal Chemistry, 9, 1359-1366.
53. Sheskin, D. J. (1997). Handbook of parametric and nonparametric statistical procedures. Boca Raton, FL: CRC Press.
54. Spielman, J., Borod, J., & Ramig, L. (2003). Effects of intensive voice treatment (LSVT) on facial expressiveness in Parkinson's disease: Preliminary data. Cognitive and Behavioral Neurology, 76(3), 177-188.
55. Spielman, J., Ramig, L., & Fox, C. (2005). Changes in vowel acoustics following intensive voice treatment in Parkinson's disease: Implications for speech intelligibility [Abstract]. Movement Disorders, 20(10), S132.
56. Stroud, A., & Belin, G. (2004, November). Effects of intensive voice treatment (LSVT) on ataxic and hypokinetic dysarthria: A group case study. Poster presented at the Annual Convention of the American Speech-Language-Hearing Association, Philadelphia.
57. Trail, M., Fox, C., Ramig, L., Sapir, S., Howard, J., & Lai, E. (2005). Speech treatment for people with Parkinson's disease. Neurorehabilitation, 20, 205-221.
58. Turner, R. S., & Anderson, M. E. (1997). Pallidal discharge related to the kinematics of reaching movements in two dimensions. Journal of Neurophysiology, 77, 1051-1074.
59. Turner, R. S., Grafton, S. T., McIntosh, A. R., DeLong, M. R., & Hoffman, J. M. (2003). The functional anatomy of parkinsonian bradykinesia. NeuroImage, 19, 163-179.
60. Turner, R. S., Grafton, S. T., Votaw, J. R., DeLong, M. R., & Hoffman, J. M. (1998). Motor subcircuits mediating the control of movement velocity: A PET study. Journal of Neurophysiology, 80, 2162-2176.
61. Vaynman, S., & Gomez-Pinilla, F. (2005). License to run: Exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabilitation and Neural Repair, 19, 283-295.
62. Wohlert, A. B. (2004). Service delivery variables and outcomes of treatment for hypokinetic dysarthria in Parkinson disease. Movement Disorders, 12, 235-239.
63. Yorkston, K. M., Spencer, K. A., & Duffy, J. R. (2003). Behavioral management of respiratory/phonatory dysfunction from dysarthria: A systematic review of the evidence. Journal of Medical Speech-Language Pathology, 11(2), 12-38.